go back

Hawaii rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Professionalmedian $562,341 · 10th–90th $537,032–$645,6540%50%10th90th$562,341$1.0K$5.0K$20.0K$100.0K$500.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $645,654.23
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $676,082.98
HMSA
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$537,031.80 / $537,031.80 / $537,031.80
Kaiser Permanente
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$524,807.46 / $676,082.98 / $851,138.04
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$407,380.28 / $512,861.38 / $575,439.94